Angitia Biopharmaceuticals Guangzhou Limited
1 clinical trials · Sponsor
◉ Watch Angitia Biopharmaceuticals Guangzhou Limited
| Record | Firm | Date |
|---|---|---|
| A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR) (NCT07557446) | Angitia Biopharmaceuticals Guangzhou Limited | 2026-06-01 |
Track Angitia Biopharmaceuticals Guangzhou Limited automatically
Every clearance here is in the API, with alerts when new ones post.